JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M611644200 on February 16, 2007

J. Biol. Chem., Vol. 282, Issue 17, 12749-12754, April 27, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/17/12749    most recent
M611644200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Textoris-Taube, K.
Right arrow Articles by Kuckelkorn, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Textoris-Taube, K.
Right arrow Articles by Kuckelkorn, U.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The N-terminal Flanking Region of the TRP2360–368 Melanoma Antigen Determines Proteasome Activator PA28 Requirement for Epitope Liberation*

Kathrin Textoris-Taube{ddagger}, Peter Henklein{ddagger}, Sylvie Pollmann{ddagger}, Theresa Bergann{ddagger}, Hardy Weisshoff§, Ulrike Seifert{ddagger}, Ilse Drung{ddagger}, Clemens Mügge§, Alice Sijts, Peter-Michael Kloetzel{ddagger}1, and Ulrike Kuckelkorn{ddagger}

From the {ddagger}Institut für Biochemie, Charité-Universitätsmedizin, D-10117 Berlin, Germany, §Institut für Chemie, Humboldt-Universität, D-12489 Berlin, Germany, and Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, University of Utrecht, 3584 CL Utrecht, Netherlands

Proteasomes are known to produce major histocompatibility complex (MHC) class I ligands from endogenous antigens. The interferon-{gamma}-inducible proteasome activator PA28 plays an important role in the generation of MHC ligands by proteasomes. Generation of the HLA-A*0201 restricted melanoma antigen TRP2360–368 by the proteasome has been shown to be dependent on the function of PA28 in vitro and in vivo (Sun, Y., Sijts, A. J., Song, M., Janek, K., Nussbaum, A. K., Kral, S., Schirle, M., Stevanovic, S., Paschen, A., Schild, H., Kloetzel, P. M., and Schadendorf, D. (2002) Cancer Res. 62, 2875–2882). Here we analyzed the role of the epitope sequence environment in determining this PA28 dependence. Experiments using the melanoma TRP2288–296 epitope and the murine cytomegalovirus-derived pp89 epitope precursor peptide for epitope replacement revealed that the TRP2360–368 flanking sequences can transfer PA28 dependence onto otherwise PA28 independent epitopes. Moreover, the N-terminal flanking sequence is sufficient to establish PA28 dependence of an epitope by allowing PA28-induced coordinated dual cleavages. These results show that N-terminal flanking sequences strongly influence epitope generation efficiency and that PA28 function is particularly relevant for the generation of normally poorly excised peptide products.


Received for publication, December 19, 2006 , and in revised form, February 8, 2007.

* This work was supported by Grants Sonderforschungsbereich (SFB) 421 (to P.-M. K.), SFB/TR 19 (to U. K.), and Deutsche Forschungsgemeinschaft Ku1261 (to U. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Monbijoustrasse 2, D-10117 Berlin, Germany. Tel.: 49-30-450-528071; Fax: 49-30-450-528921; E-mail: p-m.kloetzel{at}charite.de.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
B. Strehl, K. Textoris-Taube, S. Jakel, A. Voigt, P. Henklein, U. Steinhoff, P.-M. Kloetzel, and U. Kuckelkorn
Antitopes Define Preferential Proteasomal Cleavage Site Usage
J. Biol. Chem., June 27, 2008; 283(26): 17891 - 17897.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.